Scilex Holding (SCLX) Minority Interest (2025 - 2026)
Scilex Holding (SCLX) posted quarterly Minority Interest of -$4.9 million for Q1 2026, down 22.16% quarter-over-quarter from -$4.0 million in Q4 2025.
Scilex Holding (SCLX) Minority Interest (2025 - 2026) Analysis & Trends
Scilex Holding's Minority Interest history runs 2 years deep, the most recent figure standing at -$4.9 million for Q1 2026.
- In Q1 2026, Minority Interest changed N/A year-over-year to -$4.9 million; the TTM figure through Mar 2026 stood at -$4.9 million (changed N/A YoY), while the FY2025 annual figure was -$4.0 million, changed N/A from the prior year.
- Minority Interest for Q1 2026 stood at -$4.9 million, down from -$4.0 million in the prior quarter.
- The five-year high for Minority Interest was -$2.8 million in Q3 2025, with the low at -$4.9 million in Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.97 Bn | 635.21 Bn | 17.26 Bn |
| 2 | AbbVie | 470.01 Bn | 463.44 Bn | 12.70 Bn |
| 3 | Merck | 380.54 Bn | 373.40 Bn | 12.21 Bn |
| 4 | Novartis Ag | 302.93 Bn | 295.24 Bn | 11.24 Bn |
| 5 | Astrazeneca | 258.10 Bn | 253.20 Bn | 12.86 Bn |
| 6 | Amgen | 237.12 Bn | 223.14 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 183.14 Bn | 179.96 Bn | 6.22 Bn |
| 8 | Pfizer | 161.51 Bn | 149.81 Bn | 10.94 Bn |
| 9 | Gsk | 105.87 Bn | 101.71 Bn | 8.24 Bn |
| 10 | Scilex Holding | 39.97 Mn | -72.82 Mn | 3.97 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4.85 Mn |
| Dec 31, 2025 | -3.97 Mn |
| Sep 30, 2025 | -2.78 Mn |